Leah S Forman1, Gregory J Patts1, Sharon M Coleman1, Elena Blokhina2, John Lu1, Tatiana Yaroslavtseva2, Natalia Gnatienko3, Evgeny Krupitsky2,4, Jeffrey H Samet3,5, Christine E Chaisson1. 1. 1 Data Coordinating Center, School of Public Health, Boston University, Boston, MA, USA. 2. 2 Laboratory of Clinical Pharmacology of Addictions, Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia. 3. 3 Department of Medicine, Section of General Internal Medicine, Clinical Addiction Research and Education Unit, Boston Medical Center and Boston University School of Medicine, Boston, MA, USA. 4. 4 Department of Addictions, Bekhterev Research Psychoneurological Institute, St. Petersburg, Russia. 5. 5 Department of Community Health Sciences, School of Public Health, Boston University, Boston, MA, USA.
Abstract
BACKGROUND/AIMS: Reproducible outcomes in clinical trials depend on adherence to study protocol. Short message service (also known as text message) reminders have been shown to improve clinical trial adherence in the United States and elsewhere. However, due to systematic differences in mobile data plans, languages, and technology, these systems are not easily translated to international settings. METHODS: To gauge technical capabilities for international projects, we developed SMSMessenger, an automated Android application that uses a US server to send medication reminders to participants in a clinical trial in St. Petersburg, Russia (Zinc for HIV disease among alcohol users-a randomized controlled trial in the Russia Alcohol Research Collaboration on HIV/AIDS cohort). The application is downloaded once onto an Android study phone. When it is time for the text message reminders to be sent, study personnel access the application on a local phone, which in turn accesses the existing clinical trial database hosted on a US web server. The application retrieves a list of participants with the following information: phone number, whether a message should be received at that time, and the appropriate text of the message. The application is capable of storing multiple outgoing messages. With a few clicks, text messages are sent to study participants who can reply directly to the message. Study staff can check the local phone for incoming messages. The SMSMessenger application uses an existing clinical trial database and is able to receive real-time updates. All communications between the application and server are encrypted, and phone numbers are stored in a secure database behind a firewall. No sensitive data are stored on the phone, as outgoing messages are sent through the application and not by messaging features on the phone itself. Messages are sent simultaneously to study participants, which reduces the burden on local study staff. Costs and setup are minimal. The only local requirements are an Android phone and data plan. CONCLUSION: The SMSMessenger technology could be modified to be applied anywhere in the world, in any language, script, or alphabet, and for many different purposes. The novel application of this existing low-cost technology can improve the usefulness of text messaging in advancing the goals of international clinical trials.
RCT Entities:
BACKGROUND/AIMS: Reproducible outcomes in clinical trials depend on adherence to study protocol. Short message service (also known as text message) reminders have been shown to improve clinical trial adherence in the United States and elsewhere. However, due to systematic differences in mobile data plans, languages, and technology, these systems are not easily translated to international settings. METHODS: To gauge technical capabilities for international projects, we developed SMSMessenger, an automated Android application that uses a US server to send medication reminders to participants in a clinical trial in St. Petersburg, Russia (Zinc for HIV disease among alcohol users-a randomized controlled trial in the Russia Alcohol Research Collaboration on HIV/AIDS cohort). The application is downloaded once onto an Android study phone. When it is time for the text message reminders to be sent, study personnel access the application on a local phone, which in turn accesses the existing clinical trial database hosted on a US web server. The application retrieves a list of participants with the following information: phone number, whether a message should be received at that time, and the appropriate text of the message. The application is capable of storing multiple outgoing messages. With a few clicks, text messages are sent to study participants who can reply directly to the message. Study staff can check the local phone for incoming messages. The SMSMessenger application uses an existing clinical trial database and is able to receive real-time updates. All communications between the application and server are encrypted, and phone numbers are stored in a secure database behind a firewall. No sensitive data are stored on the phone, as outgoing messages are sent through the application and not by messaging features on the phone itself. Messages are sent simultaneously to study participants, which reduces the burden on local study staff. Costs and setup are minimal. The only local requirements are an Android phone and data plan. CONCLUSION: The SMSMessenger technology could be modified to be applied anywhere in the world, in any language, script, or alphabet, and for many different purposes. The novel application of this existing low-cost technology can improve the usefulness of text messaging in advancing the goals of international clinical trials.
Entities:
Keywords:
SMSMessenger; automated text messaging; international settings; medication reminders; mobile health intervention
Authors: Richard T Lester; Paul Ritvo; Edward J Mills; Antony Kariri; Sarah Karanja; Michael H Chung; William Jack; James Habyarimana; Mohsen Sadatsafavi; Mehdi Najafzadeh; Carlo A Marra; Benson Estambale; Elizabeth Ngugi; T Blake Ball; Lehana Thabane; Lawrence J Gelmon; Joshua Kimani; Marta Ackers; Francis A Plummer Journal: Lancet Date: 2010-11-09 Impact factor: 79.321
Authors: Thiago Martini da Costa; Bárbara Jaqueline Peres Barbosa; Durval Alex Gomes e Costa; Daniel Sigulem; Heimar de Fátima Marin; Adauto Castelo Filho; Ivan Torres Pisa Journal: Int J Med Inform Date: 2012-01-31 Impact factor: 4.046
Authors: Cristian Pop-Eleches; Harsha Thirumurthy; James P Habyarimana; Joshua G Zivin; Markus P Goldstein; Damien de Walque; Leslie MacKeen; Jessica Haberer; Sylvester Kimaiyo; John Sidle; Duncan Ngare; David R Bangsberg Journal: AIDS Date: 2011-03-27 Impact factor: 4.177
Authors: Helene Hardy; Vikram Kumar; Gheorghe Doros; Eric Farmer; Mari-Lynn Drainoni; Denis Rybin; Dan Myung; Jonathan Jackson; Elke Backman; Anela Stanic; Paul R Skolnik Journal: AIDS Patient Care STDS Date: 2011-02-16 Impact factor: 5.078
Authors: Jessica E Haberer; Angella Musiimenta; Esther C Atukunda; Nicholas Musinguzi; Monique A Wyatt; Norma C Ware; David R Bangsberg Journal: AIDS Date: 2016-05-15 Impact factor: 4.177
Authors: Natalia Gnatienko; Matthew S Freiberg; Elena Blokhina; Tatiana Yaroslavtseva; Carly Bridden; Debbie M Cheng; Christine E Chaisson; Dmitry Lioznov; Sally Bendiks; Glory Koerbel; Sharon M Coleman; Evgeny Krupitsky; Jeffrey H Samet Journal: HIV Clin Trials Date: 2018-04-17